These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 18043028)
1. Fatal intoxication with a selective serotonin reuptake inhibitor, lorazepam, and codeine. Filter ER; Gorczynski L; Fernandes JR Am J Forensic Med Pathol; 2007 Dec; 28(4):361-3. PubMed ID: 18043028 [TBL] [Abstract][Full Text] [Related]
2. Asynchronicity of Organic and Psychiatric Symptoms in a Case of Sertraline Intoxication. Pitzianti M; Marciano S; Minnei M; Baratta A; Pasini A Clin Neuropharmacol; 2016; 39(5):269-71. PubMed ID: 27454389 [TBL] [Abstract][Full Text] [Related]
3. Death from asthma associated with sertraline overdose. Carson HJ; Zweigart M; Lueck NE Am J Forensic Med Pathol; 2000 Sep; 21(3):273-5. PubMed ID: 10990292 [TBL] [Abstract][Full Text] [Related]
4. The serotonin toxidrome: shortfalls of current diagnostic criteria for related syndromes. Chiew AL; Buckley NA Clin Toxicol (Phila); 2022 Feb; 60(2):143-158. PubMed ID: 34806513 [TBL] [Abstract][Full Text] [Related]
5. Serotonin syndrome from sertraline monotherapy. Duignan KM; Quinn AM; Matson AM Am J Emerg Med; 2020 Aug; 38(8):1695.e5-1695.e6. PubMed ID: 31837902 [TBL] [Abstract][Full Text] [Related]
6. Acute fatal hepatitis related to sertraline. Fartoux-Heymann L; Hézode C; Zafrani ES; Dhumeaux D; Mallat A J Hepatol; 2001 Nov; 35(5):683-4. PubMed ID: 11690719 [No Abstract] [Full Text] [Related]
9. Fatal multiple drug intoxication following acute sertraline use. Milner DA; Hall M; Davis GG; Brissie RM; Robinson CA J Anal Toxicol; 1998 Oct; 22(6):545-8. PubMed ID: 9788533 [TBL] [Abstract][Full Text] [Related]
10. Toxicity of Bupropion Overdose Compared With Selective Serotonin Reuptake Inhibitors. Overberg A; Morton S; Wagner E; Froberg B Pediatrics; 2019 Aug; 144(2):. PubMed ID: 31278211 [TBL] [Abstract][Full Text] [Related]
12. Massive sertraline overdose. Brendel DH; Bodkin JA; Yang JM Ann Emerg Med; 2000 Nov; 36(5):524-6. PubMed ID: 11054208 [TBL] [Abstract][Full Text] [Related]
13. Antisaccade and smooth pursuit eye movements in healthy subjects receiving sertraline and lorazepam. Green JF; King DJ; Trimble KM J Psychopharmacol; 2000 Mar; 14(1):30-6. PubMed ID: 10757250 [TBL] [Abstract][Full Text] [Related]
14. Cooperative opioid and serotonergic mechanisms generate superior antidepressant-like effects in a mice model of depression. Berrocoso E; Mico JA Int J Neuropsychopharmacol; 2009 Sep; 12(8):1033-44. PubMed ID: 19341511 [TBL] [Abstract][Full Text] [Related]
15. Effects of selective serotonin reuptake inhibitor sertraline on hybrid striped bass predatory behavior and brain chemistry. Stoczynski L; van den Hurk P Aquat Toxicol; 2020 Sep; 226():105564. PubMed ID: 32683169 [TBL] [Abstract][Full Text] [Related]
16. Possible role of selective serotonin reuptake inhibitor sertraline on oxidative stress responses. Battal D; Yalin S; Eker ED; Aktas A; Sahin NO; Cebo M; Berköz M Eur Rev Med Pharmacol Sci; 2014; 18(4):477-84. PubMed ID: 24610613 [TBL] [Abstract][Full Text] [Related]
17. Aquatic ecotoxicity of the selective serotonin reuptake inhibitor sertraline hydrochloride in a battery of freshwater test species. Minagh E; Hernan R; O'Rourke K; Lyng FM; Davoren M Ecotoxicol Environ Saf; 2009 Feb; 72(2):434-40. PubMed ID: 18571724 [TBL] [Abstract][Full Text] [Related]
18. Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors. Serebruany VL; Gurbel PA; O'Connor CM Pharmacol Res; 2001 May; 43(5):453-62. PubMed ID: 11394937 [TBL] [Abstract][Full Text] [Related]
19. Additive subthreshold dose effects of cannabinoid CB(1) receptor antagonist and selective serotonin reuptake inhibitor in antidepressant behavioral tests. Takahashi E; Katayama M; Niimi K; Itakura C Eur J Pharmacol; 2008 Jul; 589(1-3):149-56. PubMed ID: 18571641 [TBL] [Abstract][Full Text] [Related]
20. Serotonin syndrome induced by augmentation of SSRI with methylphenidate. Ishii M; Tatsuzawa Y; Yoshino A; Nomura S Psychiatry Clin Neurosci; 2008 Apr; 62(2):246. PubMed ID: 18412855 [No Abstract] [Full Text] [Related] [Next] [New Search]